UNI - EN REPORT No 105/2012
Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
The Board of Directors of Sopharma AD (the "Company") hereby notifies that on 29 October 2012 was signed a merger agreement between Sopharma AD and Bulgarian Rose - Sevtopolis AD. The agreement settles both the technical process of the merger of Bulgarian Rose - Sevtopolis AD into Sopharma AD, as well as the ensuing consequences for the two companies. The contract and the accompanying documentation have been submitted to the Financial Supervision Commission.